CA2002834A1 - Xanthines cycloalkyles - Google Patents

Xanthines cycloalkyles

Info

Publication number
CA2002834A1
CA2002834A1 CA2002834A CA2002834A CA2002834A1 CA 2002834 A1 CA2002834 A1 CA 2002834A1 CA 2002834 A CA2002834 A CA 2002834A CA 2002834 A CA2002834 A CA 2002834A CA 2002834 A1 CA2002834 A1 CA 2002834A1
Authority
CA
Canada
Prior art keywords
substituted
compound
formula
unsubstituted
xanthines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2002834A
Other languages
English (en)
Other versions
CA2002834C (fr
Inventor
Harald Maschler
Rolf T. Wilke
Johannes Jukna
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Wuelfing GmbH and Co KG
Original Assignee
Beecham Wuelfing GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Wuelfing GmbH and Co KG filed Critical Beecham Wuelfing GmbH and Co KG
Publication of CA2002834A1 publication Critical patent/CA2002834A1/fr
Application granted granted Critical
Publication of CA2002834C publication Critical patent/CA2002834C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Inductance-Capacitance Distribution Constants And Capacitance-Resistance Oscillators (AREA)
  • Plural Heterocyclic Compounds (AREA)
CA002002834A 1988-11-14 1989-11-14 Xanthines cycloalkyles Expired - Fee Related CA2002834C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888826595A GB8826595D0 (en) 1988-11-14 1988-11-14 Active compounds
GB8826595.4 1988-11-14

Publications (2)

Publication Number Publication Date
CA2002834A1 true CA2002834A1 (fr) 1990-05-14
CA2002834C CA2002834C (fr) 2000-02-22

Family

ID=10646826

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002002834A Expired - Fee Related CA2002834C (fr) 1988-11-14 1989-11-14 Xanthines cycloalkyles

Country Status (14)

Country Link
EP (1) EP0369744B1 (fr)
JP (1) JPH02178283A (fr)
KR (1) KR0161261B1 (fr)
AT (1) ATE111912T1 (fr)
AU (1) AU614680B2 (fr)
CA (1) CA2002834C (fr)
DE (1) DE68918406T2 (fr)
DK (1) DK570689A (fr)
ES (1) ES2064461T3 (fr)
GB (1) GB8826595D0 (fr)
IE (1) IE65585B1 (fr)
NZ (1) NZ231380A (fr)
PT (1) PT92303B (fr)
ZA (1) ZA898678B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8918297D0 (en) * 1989-08-10 1989-09-20 Beecham Group Plc Novel treatment
GB8929208D0 (en) * 1989-12-27 1990-02-28 Almirall Lab New xanthine derivatives
JPH04112889A (ja) * 1990-09-04 1992-04-14 Kyowa Hakko Kogyo Co Ltd Ｋｓ―５０５誘導体
GB9020959D0 (en) * 1990-09-26 1990-11-07 Beecham Group Plc Novel compounds
US5342841A (en) * 1992-03-12 1994-08-30 Kyowa Hakko Kogyo Co., Ltd. Xanthine derivatives
GB9312853D0 (en) 1993-06-22 1993-08-04 Euro Celtique Sa Chemical compounds
US5591776A (en) 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
US5922751A (en) 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
JP2001523213A (ja) 1994-12-13 2001-11-20 ユーロ−セルティーク，エス．エイ． 三置換チオキサンチン類
EP0814809B1 (fr) 1994-12-13 2003-08-13 Euroceltique S.A. Aryle thioxanthines
CA2218548A1 (fr) * 1995-05-19 1996-11-21 Chiroscience Limited Xanthines et leur utilisation therapeutique
US6166041A (en) 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
US6075016A (en) 1996-04-10 2000-06-13 Euro-Celtique S.A. 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
US5864037A (en) * 1996-06-06 1999-01-26 Euro-Celtique, S.A. Methods for the synthesis of chemical compounds having PDE-IV inhibitory activity
ATE226583T1 (de) * 1996-06-07 2002-11-15 Hoechst Ag Verwendung von theophyllinderivaten zur behandlung und propylaxe von schockzuständen, neue xanthinverbindungen und verfahren zu deren herstellung
US5965555A (en) * 1996-06-07 1999-10-12 Hoechst Aktiengesellschaft Xanthine compounds having terminally animated alkynol side chains
GB9623859D0 (en) * 1996-11-15 1997-01-08 Chiroscience Ltd Novel compounds
GB9703044D0 (en) 1997-02-14 1997-04-02 Glaxo Group Ltd Phenyl xanthine esters and amides
GB9817623D0 (en) 1998-08-13 1998-10-07 Glaxo Group Ltd Pharmaceutical compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH608236A5 (fr) * 1974-01-22 1978-12-29 Wuelfing J A Fa
US4061753A (en) * 1976-02-06 1977-12-06 Interx Research Corporation Treating psoriasis with transient pro-drug forms of xanthine derivatives
CA1077932A (fr) * 1976-03-31 1980-05-20 Berlex Laboratories, Inc. Composes de la xanthine pour le traitement des bronchospasmes et des affections allergiques
DE2714953C2 (de) * 1977-04-02 1986-09-25 Hoechst Ag, 6230 Frankfurt Arzneimittel
SE416810C (sv) * 1977-10-14 1982-07-19 Draco Ab Forfarande for framstellning av xantinderivat med antiallergisk aktivitet
SE7810947L (sv) * 1978-10-20 1980-04-21 Draco Ab 3-alkylxanthines
CH643260A5 (fr) * 1980-05-02 1984-05-30 Nestle Sa 1-allyl-3-butyl-8-methylxanthine, procede de preparation et utilisation dans un medicament.
DE3525801A1 (de) * 1985-07-19 1987-01-22 Hoechst Ag Tertiaere hydroxyalkylxanthine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung

Also Published As

Publication number Publication date
JPH02178283A (ja) 1990-07-11
ZA898678B (en) 1990-09-26
DK570689D0 (da) 1989-11-14
NZ231380A (en) 1992-12-23
HK1004551A1 (en) 1998-11-27
PT92303A (pt) 1990-05-31
CA2002834C (fr) 2000-02-22
DE68918406T2 (de) 1995-03-30
IE893653L (en) 1990-05-14
KR0161261B1 (ko) 1998-12-01
AU4466789A (en) 1990-05-17
AU614680B2 (en) 1991-09-05
EP0369744A2 (fr) 1990-05-23
EP0369744A3 (fr) 1991-04-10
DK570689A (da) 1990-05-15
EP0369744B1 (fr) 1994-09-21
ES2064461T3 (es) 1995-02-01
ATE111912T1 (de) 1994-10-15
IE65585B1 (en) 1995-11-01
PT92303B (pt) 1995-07-18
KR900007842A (ko) 1990-06-02
GB8826595D0 (en) 1988-12-21
DE68918406D1 (de) 1994-10-27

Similar Documents

Publication Publication Date Title
CA2012686A1 (fr) Traitement et composes utilises pour ledit traitement
EP0369744A3 (fr) Dérivés de Xanthine, procédé pour leur préparation et compositions pharmaceutiques les contenant
CA2347588A1 (fr) Un oxazinone utilise dans la preparation du taxol et procede de preparation
AU6128590A (en) Novel compounds
EP0363212A3 (fr) Composés hétérocycliques et agents renforçant des médicaments anticancéreux qui les contiennent comme composant actif
CA2040517A1 (fr) Derives de 1,8-naphtyridin-2-one
EP0386683A3 (fr) Dérivés de xanthine à activité bronchodilatatoire, leur procédé de préparation et compositions pharmaceutiques les contenant
AU591390B2 (en) Arylcyclobutylalkyl amines and their use as antidepressive medicines
CA2053820A1 (fr) Methode d'inhibition du metabolisme du cholesterol
CA2099970A1 (fr) Compose pour le traitement du syndrome de sjoegren
IE892794L (en) Disubstituted benzylamines, their preparation process, their¹use as medicine and their synthesising agents
NZ224367A (en) Insect and mite repelling agent containing at least one substituted #a#, #l#-aminoalcohol
CA2032254A1 (fr) Derives de glycerol, mode de preparation et compositions therapeutiques en contenant
CA2164642A1 (fr) Nouveaux composes de structure benzisoselen-azolin et -azine, leur procede de preparation et leurs applications therapeutiques
CA2011238A1 (fr) Traitement pharmaceutique
EP0565146A3 (fr) Usage d'un ester thioique pour la préparation de compositions pharmaceutiques de traitement l'ischémie et de syndromes de reperfusion
EP0298423A3 (fr) Dérivé de l'antibiotique KSB-1939 et leurs méthodes de production ainsi que les agents pesticides les contenant
EP0309411A3 (fr) Dérivés de saccharides
CA2403110A1 (fr) Derives de n-desacetylthiocolchicine et compositions renfermant ces derives
CA2007785A1 (fr) 1-[3-(2-hydroxy-3-alkylaminopropoxy)-2-thienyl] -2-thienyl]-3-phenyl-1-propanones et procede de preparation
KR910005860A (ko) 항간질환성 조성물
IE890092L (en) Process for preparing hydroxyalkylating agents, the agents so obtained, and their use
CA2030911A1 (fr) Preparations pharmaceutiques
CA2038984A1 (fr) Hydroxymethylindolizidines et hydroxymethylquinolizidines
CA2086137A1 (fr) Derives de la benzofuranylimidazole, methode de preparation et compositions therapeutiques a base de ces derives

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed